FBR Capital Markets Initiates Coverage on The Advisory Board Company (ABCO)
FBR Capital Markets assumed coverage on shares of The Advisory Board Company (NASDAQ:ABCO) in a research note issued on Thursday, TheFlyOnTheWall.com reports. The firm set a “market perform” rating and a $50.00 price target on the stock. FBR Capital Markets’ target price points to a potential downside of 0.62% from the stock’s previous close.
The Advisory Board Company (NASDAQ:ABCO) opened at 50.31 on Thursday. The Advisory Board Company has a one year low of $46.37 and a one year high of $70.55. The stock’s 50-day moving average is $50.49 and its 200-day moving average is $56.54. The company has a market cap of $1.832 billion and a P/E ratio of 105.15.
The Advisory Board Company (NASDAQ:ABCO) last issued its quarterly earnings data on Thursday, July 31st. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.01. The company had revenue of $141.82 million for the quarter, compared to the consensus estimate of $141.95 million. During the same quarter in the previous year, the company posted $0.31 earnings per share. The company’s revenue for the quarter was up 15.1% on a year-over-year basis. Analysts expect that The Advisory Board Company will post $1.24 EPS for the current fiscal year.
In other The Advisory Board Company news, President David L. Felsenthal unloaded 4,272 shares of The Advisory Board Company stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $48.64, for a total transaction of $207,790.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Separately, analysts at Raymond James reiterated an “outperform” rating on shares of The Advisory Board Company in a research note on Friday, August 1st. They now have a $55.00 price target on the stock, down previously from $57.00. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $67.14.
The Advisory Board Companyprovides best practices research and analysis, software tools, and management and advisory services to the health care and education industries.
Receive News & Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related companies with Analyst Ratings Network's FREE daily email newsletter.